Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
SRPT
SRPT News & Events
-
Add to Watchlist
Trade SRPT
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
SRPT News
Transformation of Value in Biotechnology Sector
1d ago
Globenewswire
Biotechnology Sector Undergoes Value Transformation
1d ago
Newsfilter
Roche Initiates New Phase 3 Trial for Elevidys Gene Therapy
5d ago
seekingalpha
Capricor's Former Executive Considered for FDA Biologics Chief
Apr 14 2026
stocktwits
SAREPTA THERAPEUTICS INC: RBC Increases Target Price from $18 to $19
Apr 07 2026
moomoo
SAREPTA THERAPEUTICS, INC.: DEUTSCHE BANK INCREASES TARGET PRICE FROM $12 TO $14
Mar 26 2026
moomoo
SAREPTA THERAPEUTICS INC: WEDBUSH INCREASES TARGET PRICE FROM $29 TO $35
Mar 26 2026
moomoo
SAREPTA THERAPEUTICS INC: CITIGROUP INCREASES TARGET PRICE FROM $9 TO $13
Mar 26 2026
moomoo
Show More News
SRPT Events
No data
SRPT Monitor News
Sarepta Therapeutics to Submit New Drug Applications Following Positive FDA Feedback
Mar 25 2026
Sarepta's Stock Drops After Q4 Earnings Miss and CEO Retirement Announcement
Feb 26 2026
Sarepta's Elevidys Shows Significant Efficacy in DMD Study
Jan 26 2026
Sarepta Submits Clinical Trial Application for Huntington's Disease Therapy
Jan 12 2026
SRPT.O Surges Past 5-Day SMA Amid Positive Sentiment
Nov 14 2025
SRPT Earnings Analysis
No Data
People Also Watch
